Price (90d)
No price history yet — the daily price refresh runs once a day.
Signal Score (90d)
100Quote
Valuation & Ratios
Returns & Efficiency
Revenue & Net Income (Annual)
| Fiscal Year | Revenue | Net Income | EPS |
|---|---|---|---|
| 2025 | $878.9K | $122.0K | $0.01 |
| 2024 | $811.3K | $106.7K | $0.00 |
| 2023 | $792.6K | $1.6K | $0.00 |
| 2022 | $853.5K | $21.3K | $0.00 |
| 2021 | $1.00M | $96.0K | $0.00 |
Social Signal Score
Valuation
Project earnings forward and see what return today's price implies.
Seeded from IVRO's reported EPS growth of 6.5% a year over 4 years.
- EPS in 5 years
- $0.01
- Implied price
- $0.08
- Return from $0.05
- 10.7% a year
To earn 15.0% a year on these assumptions you'd need to buy at $0.04 — -17.5% below today's price.
How sensitive is that answer?
Annual return across nearby assumptions. If the result is only attractive in one corner, that is the finding.
| growth \ P/E | 7 | 9 | 11 | 13 | 15 |
|---|---|---|---|---|---|
| -3.5% | -8.4% | -3.7% | 0.3% | 3.7% | 6.7% |
| 1.5% | -3.6% | 1.3% | 5.5% | 9.1% | 12.2% |
| 6.5% | 1.1% | 6.3% | 10.7% | 14.4% | 17.7% |
| 11.5% | 5.8% | 11.3% | 15.9% | 19.8% | 23.3% |
| 16.5% | 10.6% | 16.3% | 21.1% | 25.2% | 28.8% |
This is arithmetic on assumptions you chose, not a forecast or a recommendation. It ignores dividends, buybacks, share issuance and debt, and it assumes a company still earning money in 5 years. Change any input and the answer changes a lot — that sensitivity is the honest result, not a flaw in the model.
Mentions (1)
- Newsnewsfilecorp.com·4d ago·Neutral
A Brighter Future Is on the Way Placentia, California--(Newsfile Corp. - August 11, 2026) - Today, InVitro International (OTCQB: IVRO) reported FY '26 Q3 sales of $117,760, off 24.1% from the same period in FY '25. YTD sales of $567,200, reversing 2Q trends, are now 15.9% below the same period in FY '25.
View source ↗